Location History:
- Cheshire, CT (US) (1993 - 2002)
- Waliingford, CT (US) (2007)
- Wallingford, CT (US) (2002 - 2018)
- Hopkinton, MA (US) (2021)
Company Filing History:
32 out of 3,681 
1 out of 784 
Years Active: 1993-2021
Title: **Mark D. Wittman: Innovator in Pharmaceutical Chemistry**
Introduction
Mark D. Wittman, an accomplished inventor based in Wallingford, Connecticut, has made significant contributions to the field of pharmaceutical chemistry, holding a remarkable total of 32 patents. His work primarily focuses on developing novel compounds that target critical pathways in treating various diseases, including cancer and viral infections.
Latest Patents
Among his latest innovations are two noteworthy patents. The first patent involves isofuranone compounds, which serve as hematopoietic progenitor kinase 1 (HPK1) inhibitors. The disclosed compounds, defined by specific formulas, are showcased for their potential utility in modulating or inhibiting HPK1's enzymatic activity. These compounds are particularly promising for addressing viral infections and proliferative disorders, such as cancer.
The second patent presents imidazo-pyridazine derivatives that act as inhibitors of casein kinase 1 δ/ε. These compounds are designed to inhibit protein kinase activity, positioning them as potential anticancer agents due to their therapeutic applications in oncology.
Career Highlights
Throughout his career, Mark D. Wittman has held significant positions at prominent organizations, including Bristol Myers Squibb Company and Virginia Tech Intellectual Properties, Inc. His experiences at these institutions have undoubtedly enriched his expertise and innovation capabilities in pharmaceutical research.
Collaborations
Mark has collaborated with notable coworkers such as Upender Velaparthi and John F. Kadow. Their collective efforts have contributed to driving advancements in their respective fields, advancing the understanding and treatment of various diseases through innovative research.
Conclusion
In conclusion, Mark D. Wittman's extensive portfolio of patents and his dedicated work in pharmaceutical chemistry underscore his status as a leading innovator. His research not only enhances scientific knowledge but also paves the way for developing effective treatments for health challenges, particularly in cancer and viral infections.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.